Altimmune, Inc.
Altimmune, Inc.（ALT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
alt · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$20.00
Consensus
$11.25
+315.1% upside
Low
$2.50
Median: $11.25 · Last Close: $2.71
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$11.25
315.1% upside
High Target
$20
638.0%
Low Target
$2.5
-7.7%
Current Price
$2.71
as of today
Based on analyst price targets, the ALT stock price prediction for the next 12 months ranges from $2.5 to $20. The consensus ALT price forecast of $11.25 implies 315.1% upside from the current price of $2.71.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $2.67 | ↓ 1.41% |
1-day model range: $2.65–$2.69. Peak: $2.69 (-1.41%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ALT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-03-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-06 | B. Riley Securities | Maintains | Buy→Buy |
| 2025-11-07 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | UBS | Maintains | Buy→Buy |
| 2025-08-13 | B. Riley Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Altimmune, Inc. (ALT) stock. Of the recent 64 rating actions, 0 were upgrades and 3 were downgrades. 15 analysts currently cover ALT.
分析师推荐趋势
ALT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$26M
↑ 501964.4% YoY
EPS This Year
$-0.69
EPS Next Year
$-0.76
↑ 11.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ALT EPS of $-0.69 for the current fiscal year, based on estimates from 6 analysts. The ALT revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ALT 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ALT 的共识目标价为 $11.25（+315.1% 上行空间），分析师共识为 Buy。
ALT 的短期预测（明日）为 $2.67（-1.41%）。
Altimmune, Inc. 在 NASDAQ 上市，代码 ALT。ALT 在 2027 年的整体展望偏积极，在覆盖分析师中约 80% 对应 Buy 共识。
常见问题
ALT 预测 · 8 个问题根据 15 位华尔街分析师，ALT 的 12 个月平均目标价为 $11.25，最高 $20.00、最低 $2.50。若有图表，中位目标价可在上方查看。相对当前价 $2.71，隐含约 +315.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.